Marketplace Morning Report
Marketplace Morning Report

A new era for weight-loss drugs

December 23, 2025

AI Summary

5 min read

πŸŽ™οΈ The Voices & The Context

  • The Format: This Marketplace episode delivers bite-sized economic news segments interspersed with targeted interviews, anchoring daily market insights in real-world impacts like healthcare costs and job struggles for a broad audience. Analytical and data-driven.
  • The Format: A news magazine show blending reporter dispatches, host narration, and expert interviews.
  • The Key Players:
    • Host: Sabri Benishore (filling in for David Brancaccio), guiding crisp transitions between stories with probing questions.
    • Guest Expert: Chris Farrell, Marketplace's senior economics contributor, bringing deep historical context and Fed analysis to unpack labor market paradoxes.

Continue reading the full summary in the app β€” free to try.

Read Full Summary β†’

Free β€’ No credit card required

What you'll learn

  • 1 (00:48) **GLP-1 Weight Loss Drugs: FDA Approves Oral Wegovy**
  • 2 (02:16) **Consumer Sentiment Ahead of Conference Board Index Release**
  • 3 (05:08) **Rising Long-Term Unemployment Amid Economic Expansion**

+ Full timestamped outline available in the app

Show Notes

GLP-1 weight-loss drug injections have slimmed many waistlines and wallets. U.S. regulators have now approved a much less expensive alternative; Novo Nordisk has gotten the green light for an oral version of Wegovy. Pills are cheaper to manufacture than injectables, and that could be a game-changer. Then, consumers still feel pessimistic heading into the new year, and more Americans are staying unemployed for longer.

Marketplace Morning Report